Evelyn Eggenstein

Evelyn Eggenstein is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as the Director of Commercial Operations for the US at Coriolis Pharma since July 2022. Prior to this role, Evelyn held the position of Business Development Manager for North America at Daicel Arbor Biosciences from June 2015 to July 2022, where responsibilities included managing myTXTL manufacturing and R&D activities, providing technical support, and fostering customer relationships. Earlier experiences include a Doctoral Student at the Technical University of Munich from February 2010 to January 2015, focusing on fusion proteins, and various research assistant roles at the same university. Evelyn holds a Bachelor's and a Master's degree in Molecular Biotechnology and a Doctorate from the Technical University of Munich.